Spindle orientation and nuclear migration are crucial events in cell growth and differentiation of many eukaryotes. Here we show that KIP3, the sixth and final kinesin-related gene in Saccharomyces cerevisiae, is required for migration of the nucleus to the bud site in preparation for mitosis. The position of the nucleus in the cell and the orientation of the mitotic spindle was examined by microscopy of fixed cells and by time-lapse microscopy of individual live cells. Mutations in KIP3 and in the dynein heavy chain gene defined two distinct phases of nuclear migration: a KIP3-dependent movement of the nucleus toward the incipient bud site and a dynein-dependent translocation of the nucleus through the bud neck during anaphase. Loss of KIP3 function disrupts the unidirectional movement of the nucleus toward the bud and mitotic spindle orientation, causing large oscillations in nuclear position. The oscillatory motions sometimes brought the nucleus in close proximity to the bud neck, possibly accounting for the viability of a kip3 null mutant. The kip3 null mutant exhibits normal translocation of the nucleus through the neck and normal spindle pole separation kinetics during anaphase. Simultaneous loss of KIP3 and kinesin-related KAR3 function, or of KIP3 and dynein function, is lethal but does not block any additional detectable movement. This suggests that the lethality is due to the combination of sequential and possibly overlapping defects. Epitope-tagged Kip3p localizes to astral and central spindle microtubules and is also present throughout the cytoplasm and nucleus.
Skip Nav Destination
Article navigation
8 September 1997
Article|
September 08 1997
Kinesin-related KIP3 of Saccharomyces cerevisiae Is Required for a Distinct Step in Nuclear Migration
Todd M. DeZwaan,
Todd M. DeZwaan
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Eric Ellingson,
Eric Ellingson
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
David Pellman,
David Pellman
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
David M. Roof
David M. Roof
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Todd M. DeZwaan
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Eric Ellingson
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
David Pellman
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
David M. Roof
*Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6085; and ‡Departments of Pediatric Oncology, The Dana-Farber Cancer Institute, and Pediatric Hematology, The Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115
Address all correspondence to David M. Roof, Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6085. Tel.: (215) 573-3636. Fax: (215) 573-5851. E-mail:[email protected]
Received:
May 19 1997
Revision Received:
July 03 1997
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 138 (5): 1023–1040.
Article history
Received:
May 19 1997
Revision Received:
July 03 1997
Citation
Todd M. DeZwaan, Eric Ellingson, David Pellman, David M. Roof; Kinesin-related KIP3 of Saccharomyces cerevisiae Is Required for a Distinct Step in Nuclear Migration . J Cell Biol 8 September 1997; 138 (5): 1023–1040. doi: https://doi.org/10.1083/jcb.138.5.1023
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement